The Rythmia Plant Medicine Company – a profitable medicinal plant medicine company

A company with the potential to be one of the biggest in the country is set to open its doors to the public this year, with the aim of helping to improve the lives of many of the country’s poorest residents.

The Rythmias plant medicine business is set up by the Rythia family and is based in Cumbria, a county near the UK border.

It is the first plant medicine manufacturing company in the UK, with a portfolio of products including medicinal plants, herbal remedies and cosmetics.

Dr Rythias said that the Rythmia family had invested in plant medicine since the 1950s and that its aim was to create a range of products that could benefit the wider community.

The plant medicine products, which range from medicinal tea, to medicinal flowers and flowers of the family petunia, are now sold in more than 150 countries.

Dr Paul Rythis said the company was now in a position to offer products to a wider range of patients, particularly those living in poverty.

“I think this is an opportunity for us to expand our product line in the area of plant medicine and provide some really good value to the community, to people living in communities that are struggling,” he said.

“The plants in the family, the petunia flower, is very important to the family and so we are hoping to grow our business.”

Plant medicine is a wide-ranging field, with products such as tea, honey, tea leaf, extracts, tonics and sprays being sold worldwide.

The main ingredient in many of these products is the Rhamnias plant, which is native to South America.

However, there is growing interest in the use of the Rhaetia plant for a number of other uses.

The UK has been the focus of growing interest from around the world as it has seen a steady increase in the number of people with chronic illnesses due to the introduction of cannabis into the UK.

Many people in Britain are also concerned about the rise of the cannabis plant in the past few years, particularly in the north east.

Cannabis is an illegal substance and has been shown to increase the risk of psychosis and depression.

Dr Simon Rythas said the family had been making progress in the last few years but was currently looking to the future.

“It is a really exciting opportunity to be able to offer this product, and to offer it to the wider population,” he told BBC Radio Cumbrian.

“We are going to be doing a lot of trials with the patients that we serve.”

‘It is very hard to make it’ Dr Rynas said that there was a real need for a plant medicine to be available for those who needed it, especially those who were suffering from a variety of chronic illnesses.

“If you have arthritis, diabetes, it is really hard to find a plant that is suitable to help with these conditions,” he explained.

“For some of these people, it would be very difficult to go to a plant specialist and get the right plant for them.”

Dr Ryneas said he hoped that by providing a range a range products that can be used to treat a wide range of illnesses, it could become more accessible to more people.

“This is a very important area, especially in areas that have very low access to health care, but also in places that have high access to it,” he added.

“So, I think the more we can bring in more of these options, the better for all of us.”

The company’s business is supported by a number grant and funding sources, including the University of York’s Centre for Medical Research, the Medical Research Council and the British Medical Research Institute.

The company is expected to open a new factory in 2016.